Goldman Sachs’s Astria Therapeutics ATXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.67M | Buy |
|
|||||
|
2025
Q2 | $950K | Buy |
|
|||||
|
2025
Q1 | $847K | Sell |
|
|||||
|
2024
Q4 | $1.94M | Sell |
|
|||||
|
2024
Q3 | $2.99M | Sell |
|
|||||
|
2024
Q2 | $3.6M | Buy |
|
|||||
|
2024
Q1 | $3.01M | Buy |
|
|||||
|
2023
Q4 | $126K | Sell |
|
|||||
|
2023
Q3 | $213K | Buy |
|
|||||
|
2023
Q2 | $214K | Sell |
|
|||||
|
2023
Q1 | $960K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $99K | Sell |
|
|||||
|
2021
Q2 | $170K | Buy |
|
|||||
|
2021
Q1 | $101K | Buy |
|
|||||
|
2020
Q4 | $34K | Sell |
|
|||||
|
2020
Q3 | $190K | Sell |
|
|||||
|
2020
Q2 | $270K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $24K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $31K | Buy |
|
|||||
|
2016
Q4 | $46K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $56K | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $305K | Buy |
|